Advanced Weight Management
GLP-1 Medication Assessment
GLP-1 medication may be considered as part of medically supervised weight management when your clinical assessment supports its use. It is not appropriate for everyone. Your clinician will review eligibility, medical history, interactions and contraindications, and explain the prescribed medicine’s risks, monitoring requirements and alternatives. No specific medicine or dose is promised before assessment.
Concerns it may address
- Weight-related health concerns requiring assessment
- Considering prescription weight-management support
Why suitability matters
Eligibility depends on your clinical assessment and the specific medicine. Tell your clinician about all medicines, previous pancreatitis or gallbladder problems, and pregnancy or plans for pregnancy. A prescription is not guaranteed.
What to expect
Medication assessment
Review eligibility, medical history, current medicines and alternatives.
Prescribing, if suitable
Your clinician explains the selected medicine and agrees an individual treatment plan.
Monitoring
Follow-up reviews address response, side effects and whether treatment should continue.
Potential benefits
- May support weight management in eligible individuals
- Clinical monitoring of treatment response and tolerance
Limitations
- Prescription and eligibility are assessed individually
- Outcomes vary; weight regain can occur after stopping medication
- Medication does not replace nutrition, activity and ongoing support
Risks
- Nausea, vomiting, diarrhoea or constipation
- Dehydration and gallbladder problems; pancreatitis is a rare serious risk
- Low blood sugar risk may increase with certain diabetes medicines
- Medicine-specific contraindications, interactions and pregnancy restrictions require review
Frequently asked questions
From the Elixir Journal
Meet our cliniciansYour consultation
Begin with a conversation.
Book a private consultation, in person in East Legon or online, and discuss what feels right for you.